Prolongation of survival of pigs with ischemic liver failure by treatment with a bioartificial liver using glutamine synthetase transfected recombinant HepG2.
Department of Experimental Surgery and Bioengineering, National Children's Medical Research Center, Tokyo, Japan.
S
S
Enosawa
T
T
Miyashita
H
H
Tanaka
X
X
Li
S
S
Suzuki
H
H
Amemiya
T
T
Omasa
K
K
Suga
T
T
Matsumura
D000818:Animals; D002460:Cell Line; D002470:Cell Survival / Q000502:physiology; D005974:Glutamate-Ammonia Ligase / Q000235:genetics*; D022781:Hepatocytes / Q000502:physiology*; D007511:Ischemia / Q000150:complications; D008099:Liver / Q000098:blood supply; D017093:Liver Failure / Q000401:mortality / Q000628:therapy*; D019164:Liver, Artificial; D013552:Swine; D013997:Time Factors; D014162:Transfection
D005974:Glutamate-Ammonia Ligase